Chemed Corporation Financials

Market Capitalization $6.18 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	22.78
Forward PE	16.79
Price to Sales TTM	$2.46
Price to Book MRQ	$5.61
Enterprise to Revenue	2.39
Enterprise to EBITDA	14.68

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-09-30
Profit Margin	11.02%
Operating Margin	11.96%
Return on Assets TTM	12.97%
Return on Equity TTM	24.11%

Income Statement

Revenue TTM	$2,530,633,984
Revenue per Share TTM	$173.17
Quarterly Revenue Growth	3.10%
Gross Profit TTM	$832,131,008
EBITDA	$446,869,000
Net Income to Common TTM	$278,806,016
Diluted EPS TTM	$18.78
Quarterly Earnings Growth YoY	-15.20%

Balance Sheet

Total Cash MRQ	$129,752,000
Total Cash per Share MRQ	$9.20
Total Debt MRQ	$
Total Debt to Equity MRQ	13.14
Current Ratio MRQ	1.35
Book Value per Share MRQ	$76.31

Cash Flow

Operating Cash Flow TTM	$419,652,000
Levered Free Cash Flow TTM	$278,543,616

CHE Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	14,108,915
Float Shares	13,877,247
Avg 10 Volume	124,870
Avg 30 Volume	None
Shares Short	655,243
Short Ratio	4.61
Short % of Shares	5.41%
% Held by Insiders	2.01%
% Held by Institutions	101.56%

Stock Price Summary

Beta	0.46
Fifty Two Week Low	$408.42
Fifty Two Week High	$623.61
Fifty Two Week Change	-24.47%
Day 50 MA	$435.29
Day 200 MA	$492.09

Dividends and Splits

Forward Annual Dividend Rate	$2.40
Forward Annual Dividend Yield	0.57%
Trailing Annual Dividend Rate	$2.20
Trailing Annual Dividend Yield	0.52%
Payout Ratio	11.11%
Dividend Date	2025-12-05
Ex Dividend Date	2025-11-17
Last Split Factor
Last Split Date	2005-05-12